Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 21 Jun 21 424B4 Prospectus supplement with pricing info
- 18 Jun 21 EFFECT Notice of effectiveness
-
14 Jun 21 S-1/A IPO registration (amended)
- 4 Jun 21 S-1/A IPO registration (amended)
- 28 May 21 S-1 IPO registration
CYT similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 26, 2021 (except for Note 14(b), as to which the date is June 14, 2021), in Amendment No. 2 to the Registration Statement (Form S-1 No. 333-256601) and related Prospectus of Cyteir Therapeutics, Inc. dated June 14, 2021 for the registration of shares of its common stock.
/s/ Ernst & Young LLP |
Boston, Massachusetts |
June 14, 2021 |